Andrew Giliam
Andrew Giliam is a Director in our Corporate & Commercial practice.
About Andrew
About Andrew
Andrew joined Cliffe Dekker Hofmeyr as Candidate Attorney in 2015. He was appointed as an Associate January 2017 and in 2020 he was promoted to Senior Associate. Andrew was appointed Director in 2022.
Credentials
Credentials
Education
- Registered with the Legal Practice Council
- BA, University of Cape Town (UCT)
- LLB (magna cum laude), University of Cape Town (UCT)
- Year of admission as an attorney: 2017
Languages
Languages
- English
About Andrew
Andrew joined Cliffe Dekker Hofmeyr as Candidate Attorney in 2015. He was appointed as an Associate January 2017 and in 2020 he was promoted to Senior Associate. Andrew was appointed Director in 2022.
Credentials
Education
- Registered with the Legal Practice Council
- BA, University of Cape Town (UCT)
- LLB (magna cum laude), University of Cape Town (UCT)
- Year of admission as an attorney: 2017
Languages
- English
Experience
Acted for RMB Ventures Eight and Bope Moruo Fund II in their acquisition of 60% of the shares in Icon Oncology Holdings (Pty) Ltd, a private company focussed on radiotherapy and chemotherapy treatment for cancer patients and a supporting pharmacy business.
Acted for RMB Ventures Eight and Bope Moruo Fund II in their acquisition of a minority stake in Aurex Constructors, which also facilitated reinvestment by management and key staff through a employee share structure.
Acted for MSC II Investments in its acquisition of shares in the Africa Ren Platform, which included parallel investments in an AssetCo, an DevCo and an OpCo, each of which plays a different role in the Africa Ren value chain. Africa Ren's business is focussed on the identification, development and operation of renewable energy projects across Africa.
Acted for Engie in its acquisition of 100% of the BioTherm Energy Group in South Africa, which includes a portfolio of 5 operational renewable energy projects and a large pipeline of projects in development.
Represented the Evolution Funds in their acquisition of an equity stake alongside FMO and STOA Infra & Energy in the Red Rocket Group of companies. This was a follow on investment for the Evolution II Fund and was aimed at securing capital from strategic investors for the growth of Red Rocket's business.
Represented MSC II Investments in its investment for an equity stake in the Wetility group of companies, which provides rooftop solar solutions to consumers in South Africa. This investment was given effect to by way of a convertible loan agreement that was convertible into equity at the election of MSC II Investments.
Acted for Old Mutual Life Assurance Company (South Africa) Limited in the reorganisation of its Infrastructural, Developmental and Environmental Assets Managed Fund (the IDEAS Fund), which involved the transfer of approximately 60 infrastructural projects from OMLACSA to a newly establish en commandite partnership structure through a number of reorganizational steps.
Acted as issuer's counsel to Libstar Holdings Ltd in respect of its South African and international placement of shares and subsequent listing of its issued shares on the JSE.
Acted for Metier Capital Growth Fund II and Lereko Metier Capital Growth Fund I in relation to a scheme of arrangement in respect of then JSE listed company Master Plastics Ltd.
Acted for Séché Environnement S.A. and Séché South Africa (Pty) Ltd in relation to a scheme of arrangement in respect of then JSE listed company Interwaste Holdings Ltd.
Acted for Evolution Fund I in a secondary transaction involving the disposal of its equity investments in 5 portfolio companies participating in round 1 of the South African IPP Programme, through a competitive bid process in 2016/2017.
Acted for various sponsors, developers and project companies under the South African IPP Programme, including the following – 2016 – 2018: Advised Old Mutual Life Assurance Company (South Africa) Ltd in relation to the acquisition of a portfolio of 6 solar photovoltaic projects purchased from SunEdison and in the projects subsequent achievement of financial close under round 4 of the IPP Programme.
News
The route from A to DD: A roadmap for a successful due diligence
The value of a thorough due diligence process in any merger/acquisition transaction cannot be overstated. Not only does a due diligence (DD) provide comfort to an investor that the...
The benefits and pitfalls of constituting a voluntary audit committee
When it comes to audit committees, a private company is not required to appoint an audit committee unless it is required to do so by its memorandum of incorporation (MOI). Nevertheless,...
W&I insurance – A key consideration for M&A transactions
Warranty and indemnity (W&I) insurance has become increasingly familiar to the South African M&A market in recent years. This has been driven, in part, by transacting parties gaining...
More time means more money – negotiating protections against the relaxation of time-bar clauses
The benefits of arbitration are well-known. It is often cheaper, quicker and allows the parties flexibility to a process that suits their needs. Moreover, the process, pleadings, agreements...
Walking the tightrope – guidelines for defining your malus and clawback policy
There is a growing trend in South Africa towards businesses adopting malus and clawback policies in relation to their variable pay structures and employee incentive schemes. This trend...
Market recognition
- IFLR1000 2021 - 2024 recommended Andrew as a highly regarded rising star for M&A.
Market recognition
- IFLR1000 2021 - 2024 recommended Andrew as a highly regarded rising star for M&A.